MetaCap

Prelude Therapeutics Incorporated Company Profile

NASDAQ: PRLDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.23-0.025 (-0.77%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Prelude Therapeutics at a glance

Prelude Therapeutics Incorporated (NASDAQ: PRLD) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Wilmington, DE. Prelude Therapeutics is led by Dr. Krishna Vaddi D.V.M., Ph.D. and employs about 79 people. The company's shares have traded publicly since 2020.

At a market capitalization of $260.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001678660, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Prelude Therapeutics do?

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for the treatment of myeloproliferative neoplasms, myelofibrosis (MF), polycythemia vera, and essential thrombocythemia (ET); KAT6A for the treatment of advanced breast cancer and other solid tumors; and mutated calreticulin degrader antibody conjugates to treat MF and ET. The company has collaboration with AbCellera Biologics to discover, develop, and commercialize novel degrader antibody conjugates. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.

Business description based on the company's public filings.

Company information

Legal name
Prelude Therapeutics Incorporated
Ticker
NASDAQ: PRLD
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Krishna Vaddi D.V.M., Ph.D.
Employees
79
Headquarters
175 Innovation Boulevard, Wilmington, DE, United States
Phone
302 467 1280
IPO year
2020
Market cap
$260.63M
SEC CIK
0001678660
Latest annual report
10-K · Mar 10, 2026

Companies similar to Prelude Therapeutics

PRLD peer companies
CompanyPrice% ChgMarket capCompare
EBSEmergent BioSolutions Inc.5.05-1.94%$259.65Mvs PRLD
ALTAltimmune Inc.1.33-5.67%$258.80Mvs PRLD
VCREVicore Pharma Holding AB ADR9.41-5.09%$264.89Mvs PRLD
GALTGalectin Therapeutics Inc.2.69-4.27%$271.35Mvs PRLD
QTTBQ32 Bio Inc.8.34-1.65%$249.57Mvs PRLD
TTRXTurn Therapeutics Inc.8.10-6.31%$247.49Mvs PRLD
LFCRLifecore Biomedical Inc.6.39+0.31%$242.22Mvs PRLD
RLMDRelmada Therapeutics Inc.2.62-15.76%$279.54Mvs PRLD

Related